In DKA, when should glucose be added to the intravenous fluids?

In managing diabetic ketoacidosis (DKA), it is crucial to monitor blood glucose levels closely while administering intravenous fluids and insulin therapy. The appropriate time to add glucose to the intravenous fluids is typically when blood glucose levels fall to around 250-300 mg/dL.

This range is significant because it helps prevent hypoglycemia during the treatment of DKA. As insulin therapy begins to effectively lower glucose levels and address ketosis, the risk of the patient becoming hypoglycemic increases, especially if fluids without dextrose are continued. By adding glucose at this point, healthcare providers can maintain adequate blood glucose levels while also ensuring the patient's ketoacidotic state is being addressed effectively.

Timing the addition of glucose correctly is essential to achieve a balance that supports ongoing metabolic recovery without posing risks of hypoglycemia. Therefore, monitoring both glucose levels and the patient's overall clinical status is vital throughout the treatment process.